Return to warmwell.com
Bovine Tuberculosis: Disease Control
Dan Rogerson: To ask the Secretary of State for Environment, Food and Rural Affairs how much his Department has received from the salvage of carcasses or part carcasses of bovine tuberculosis reactor, inconclusive or dangerous contact cattle sold into the food chain in (a) 1986-96 and (b) 1997 to date; and how such receipts are accounted for in his Department's analysis of its expenditure on bovine tuberculosis. 
Jim Fitzpatrick: Receipts in each of the last 10 complete financial years, for cattle culled for TB control reasons, are shown as follows. We are not able to provide details of receipts back to 1986 without incurring disproportionate cost.
26 Oct 2009 : Column 43W
In terms of how these receipts are accounted for in analyses of expenditure, we either use a TB compensation figure net of salvage receipts or provide TB compensation spend figures and salvage receipt figures separately.
Bovine Tuberculosis: Vaccination
Mr. Drew: To ask the Secretary of State for Environment, Food and Rural Affairs what recent discussions he has had with his counterparts in the government of (a) the Republic of Ireland and (b) New Zealand on the vaccination of badgers against bovine tuberculosis; and if he will make a statement. 
The majority of DEFRA's TB vaccine research programme is led by researchers at the Veterinary Laboratories Agency, who collaborate with researchers in both the Republic of Ireland and New Zealand. DEFRA officials have met with their counterparts from the Republic of Ireland and representatives of the industry-led New Zealand Animal Health Board several times recently to discuss work programmes and ensure a coordinated research effort, particularly in regards to the design of badger vaccine field studies and licensing requirements for the use of the BCG vaccine against TB.